Monday - Friday, 6:00 - 7:00 PM ET In a Tuesday interview with CNBC's Jim Cramer, AstraZeneca CEO Pascal Soriot explained why the drugmaker believes it can almost double revenue by the end of the ...

Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some of ...

A new pill developed by the British pharma firm AstraZeneca appears to help people lose a similar amount of weight to other ...

Pharma company AstraZeneca has publicly released preclinical data from more than 50 of its medicines in order to find new drug combinations for cancer treatments. The data AstraZeneca released will be ...

AstraZeneca PLC on Monday said the US Food & Drug Administration has accepted and granted priority review to a supplemental biologics licence application for Ultomiris as a treatment for adults with ...

AstraZeneca disputed the complainants' versions of events in its responses to PMCPA. AstraZeneca has refuted allegations its staff “refuse to cooperate and respect” the U.K. marketing code. The ...

AstraZeneca's Cambridge Biomedical Campus in Cambridge, England, including the Discovery Center (AstraZeneca) AstraZeneca’s growing presence in China will play a key role in the Big Pharma’s cell ...

Controlling the entire cell therapy production process—from material receipt to product release—is “essential,” according to AstraZeneca, which says its new $300 million manufacturing facility will be ...

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca has entered into a definitive agreement to acquire Gracell Biotechnologies Inc. (Gracell, NASDAQ: GRCL), a global clinical-stage biopharmaceutical ...

AstraZeneca has succumbed to pressure from US president Donald Trump to reduce the cost of its medications for American patients. The Cambridge-headquartered pharmaceutical giant announced it will ...